検索
Tevogen Bio Holdings Inc
TVGNウォッチリストに追加
6.690USD
-0.030-0.45%
終値 07-31 16:00（ET）15分遅れの株価
537.98K時価総額
損失額直近12ヶ月PER
詳細情報 Tevogen Bio Holdings Inc 企業名
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.
Tevogen Bio Holdings Incの企業情報
企業コードTVGN
会社名Tevogen Bio Holdings Inc
上場日Nov 04, 2021
最高経営責任者「CEO」Saadi (Ryan)
従業員数18
証券種類Ordinary Share
決算期末Nov 04
本社所在地15 Independence Boulevard, Suite #210
都市WARREN
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号07059
電話番号16468078832
ウェブサイトhttps://tevogen.com/
企業コードTVGN
上場日Nov 04, 2021
最高経営責任者「CEO」Saadi (Ryan)
Tevogen Bio Holdings Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
Dr. Ryan Saadi, M.D.
Dr. Ryan Saadi, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Curtis Patton
Dr. Curtis Patton
Independent Director
Independent Director
--
--
Mr. Victor Sordillo
Mr. Victor Sordillo
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kirti Desai
Mr. Kirti Desai
Chief Financial Officer
Chief Financial Officer
242.98K
+16.46%
Dr. Neal Flomenberg, M.D.
Dr. Neal Flomenberg, M.D.
Chief Scientific Officer and Global R&D Lead
Chief Scientific Officer and Global R&D Lead
74.52K
+3.25%
Mr. Jeffrey Feike
Mr. Jeffrey Feike
Independent Director
Independent Director
54.03K
+74.03%
Dr. Keow Lin (Lindee) Goh
Dr. Keow Lin (Lindee) Goh
Independent Director
Independent Director
46.28K
+86.43%
Ms. Susan M. Podlogar
Ms. Susan M. Podlogar
Independent Director
Independent Director
46.28K
+86.43%
Mr. Sadiq Khan
Mr. Sadiq Khan
Chief Commercial Officer
Chief Commercial Officer
4.00K
--
よくある質問
Tevogen Bio Holdings Incの上位5名の株主は誰ですか？
Tevogen Bio Holdings Incの上位5名の株主は以下のとおりです。Mr. Kirti Desai
Tevogen Bio Holdings Inc（TVGN）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Tevogen Bio Holdings Incの株式を保有している機関は115社あり、保有株式の総市場価値は約168.15Kで、全体の4.02%を占めています。2025Q4と比較して、機関の持ち株は-44192.00増加しています。